These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20598566)

  • 21. Malignant hepatic tumors: safety of high-dose percutaneous ethanol ablation therapy.
    Redvanly RD; Chezmar JL; Strauss RM; Galloway JR; Boyer TD; Bernardino ME
    Radiology; 1993 Jul; 188(1):283-5. PubMed ID: 8390070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma: CT appearance after percutaneous ethanol ablation therapy.
    Amin Z; Lees WR; Bown SG
    Radiology; 1993 Sep; 188(3):882-3. PubMed ID: 8394592
    [No Abstract]   [Full Text] [Related]  

  • 23. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics.
    Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W
    Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous ethanol injection for hepatocellular carcinoma originating in the caudate lobe.
    Shibata T; Kubo S; Tabuchi T; Maetani Y; Ametani F; Itoh K; Konishi J
    Hepatogastroenterology; 2000; 47(33):824-7. PubMed ID: 10919039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR-guided percutaneous ethanol injection for hepatocellular carcinoma in a 0.2T open MR system.
    Kim YJ; Raman SS; Yu NC; Lu DS
    J Magn Reson Imaging; 2005 Oct; 22(4):566-71. PubMed ID: 16161074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy.
    Lee MJ; Mueller PR; Dawson SL; Gazelle SG; Hahn PF; Goldberg MA; Boland GW
    AJR Am J Roentgenol; 1995 Jan; 164(1):215-20. PubMed ID: 7998542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
    Ueno H; Okada S; Okusaka T; Ikeda M; Tanaka N; Sakamoto M; Yoshimori M
    Hepatogastroenterology; 2001; 48(41):1430-4. PubMed ID: 11677980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is choledocholithiasis a late complication of nonresectional therapies for hepatocellular carcinoma?
    Koda M; Murawaki Y; Idobe Y; Horie Y; Suou T; Kawasaki H; Ikawa S
    Hepatogastroenterology; 1999; 46(30):3091-4. PubMed ID: 10626167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of hepatocellular carcinoma (HCC): treatment with local application of alcohol and interleukin 2 (IL-2).
    Krastev Z; Koltchakov V; Popov D; Alexiev A; Koten JW; Den Otter W
    Hepatogastroenterology; 2003; 50(53):1647-9. PubMed ID: 14571807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local ablation therapy for hepatocellular carcinoma.
    Okada S
    Semin Liver Dis; 1999; 19(3):323-8. PubMed ID: 10518311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination therapy of percutaneous mitoxantrone injection, percutaneous ethanol injection, and transcatheter arterial embolization for intrahepatic hepatocellular carcinoma and adrenal metastasis.
    Kiba T; Numata K; Kitamura T; Morita K; Saito S; Sekihara H
    Hepatogastroenterology; 2001; 48(38):427-31. PubMed ID: 11379324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Management of complications associated with local ablation therapy for hepatocellular carcinoma].
    Obi S; Shiina S; Imamura M; Teratani T; Satoh S; Koike Y; Ishikawa T; Akamatsu M; Fujishima T; Tateishi R; Omata M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():606-11. PubMed ID: 11762021
    [No Abstract]   [Full Text] [Related]  

  • 33. Percutaneous ethanol injection of hepatic tumors: single-session therapy with general anesthesia.
    Livraghi T; Lazzaroni S; Pellicanò S; Ravasi S; Torzilli G; Vettori C
    AJR Am J Roentgenol; 1993 Nov; 161(5):1065-9. PubMed ID: 8273612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol ethanol mixture: phase II study.
    Yu SC; Hui EP; Wong J; Wong H; Mo F; Ho SS; Wong YY; Yeo W; Lai PB; Chan AT; Mok TS
    J Vasc Interv Radiol; 2008 Jan; 19(1):95-103. PubMed ID: 18192473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic vascular and bile duct injury after ethanol injection therapy for hepatocellular carcinoma.
    Koda M; Okamoto K; Miyoshi Y; Kawasaki H
    Gastrointest Radiol; 1992; 17(2):167-9. PubMed ID: 1312968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Minimally invasive percutaneous ablation of malignant hepatic tumors].
    Holtkamp W
    Onkologie; 2001 Feb; 24 Suppl 1():59-64. PubMed ID: 11441312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of hepatocellular carcinoma by percutaneous interventional methods.
    Livraghi T; Meloni F
    Hepatogastroenterology; 2002; 49(43):62-71. PubMed ID: 11941986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flash echo gray scale imaging with subtraction in assessment of small hepatocellular carcinoma treated with percutaneous ethanol injection: preliminary report.
    Wang JH; Lu SN; Changchien CS; Lee CM; Tung HD; Chen TM
    J Ultrasound Med; 2001 May; 20(5):539-44. PubMed ID: 11345112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma.
    Kurokohchi K; Masaki T; Watanabe S; Nakai S; Deguchi A; Morishita A; Yoneyama H; Ohgi T; Ono M; Yoshitake A; Kako T; Ohmachi N; Kiuchi T; Maeta T; Yoshida M; Mori Y; Kohi F; Kuriyama S
    Int J Oncol; 2006 Apr; 28(4):971-6. PubMed ID: 16525648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.